The BLOC1S5 Knockout HAP1 Polyclonal Cells are a genetically heterogeneous knockout population of HAP1 cells generated using CRISPR/Cas9 technology to disrupt the BLOC1S5 gene. This polyclonal product allows researchers to study BLOC1S5 loss-of-function in a near-haploid human cell model, avoiding the selection biases inherent in clonal cell lines. The population captures a wide spectrum of editing events, enabling robust and reproducible phenotypic analyses in functional genomics and drug screening applications.
The HAP1 cell line is a human haploid fibroblast-like line derived from the KBM-7 chronic myeloid leukemia cell line. Its near-haploid karyotype simplifies genetic studies, requiring only a single allelic disruption for complete gene knockout. HAP1 cells retain functional pathways relevant to membrane trafficking, signal transduction, and organelle biogenesis, making them an excellent host for investigating genes involved in lysosome-related organelle formation and associated disorders.
BLOC1S5 is an integral subunit of the BLOC-1 complex, which orchestrates endosomal cargo sorting toward lysosome-related organelles such as melanosomes and platelet dense granules. The BLOC-1 complex, comprising BLOC1S1, BLOC1S2, BLOC1S4, DTNBP1, PLDN, and SNAPIN, physically interacts with the AP-3 adaptor complex to direct trafficking of melanogenic enzymes including tyrosinase and TYRP1. Upstream, the MITF transcription factor positively regulates BLOC1S5 expression, while downstream effects involve Rab32/38-mediated vesicle transport and VAMP7-dependent fusion events. Disruption of BLOC1S5 compromises these interactions, leading to aberrant cargo delivery and impaired organelle biogenesis, closely mimicking the cellular defects observed in Hermansky-Pudlak syndrome.
In the HAP1 background, BLOC1S5 knockout polyclonal cells provide an ideal platform for dissecting the molecular mechanisms of BLOC-1-dependent endosomal sorting. The haploid nature ensures that functional deficiencies are directly attributable to the targeted gene disruption, facilitating quantitative assays of melanosome maturation and platelet dense granule formation. The polyclonal composition reduces the risk of compensatory mutations or survival selection, yielding a more faithful population-level model for studying protein trafficking defects and for screening potential modulators of BLOC-1 function.
These cells are suitable for a wide range of research applications, including co-immunoprecipitation and western blotting to assess BLOC-1 complex integrity, immunofluorescence microscopy to visualize melanosomal markers such as tyrosinase, and pigmentation assays to monitor melanin production. They can also be employed in flow cytometry-based granularity analysis and electron microscopy to evaluate platelet dense granule biogenesis in a surrogate cell model. Additionally, the knockout population serves as a cellular model for Hermansky-Pudlak syndrome, enabling the testing of small molecules or genetic rescue strategies aimed at restoring lysosome-related organelle function. For more details or technical inquiries, please contact Ascent Research.
